Article

Howard Hochster, MD, Explains Colorectal Cancer Screening Guidelines

Howard S. Hochster, an oncologist at Yale Cancer Center who specializes in gastrointestinal cancers, explains when and why individuals should consider colorectal cancer screening.

Howard S. Hochster, an oncologist at Yale Cancer Center who specializes in gastrointestinal cancers, explains that screening for colon cancer is recommended to begin at age 50 due to the increase in cancer incidence at that age. However, adults under 50, including those who may be considered at high risk due to factors related to genetics or lifestyle, can also be diagnosed with the disease. "It's still kind of rare to have people in their 40s develop colorectal cancer," he says, but it does happen.

Current guidelines recommend individuals age 50 and older receive colonoscopies every 10 years if they do not have a history of polyps. If a screening exam has identified polyps, more frequent colonoscopies may be recommended.

For people who are at higher risk, they should be screened earlier, around age 40, he says. A common high-risk factor includes having a first-degree relative with a history of colorectal cancer, especially if that family member was diagnosed before age 55.

For more information on colorectal cancer screening and prevention, visit https://www.curetoday.com/tumor/colorectal

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man.
Image of doctor.
CURE spoke with Andy Guinigundo to discuss the role that biomarkers play for patients with breast cancer.
Colorectal cancer is on the rise among younger adults, although potential explanations for the cause of this trend are likely years away.
Dr. Valerie Lee discussed emerging targeted therapies and personalized medicine approaches that are showing promise for those with gastrointestinal cancer.
Image of doctor.
Although late-stage kidney cancer generated poor survival rates for over two decades, significant progress is being made in the treatment of the disease.
There are a number of reasons why patients with cancer are encouraged to enroll in clinical trials, Dr. Michael J. Pishvaian explained.
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Related Content